Cytek Biosciences, Inc. (CTKB) at a glance

Cytek Biosciences, Inc. (CTKB) is a small-cap Healthcare company. It trades at $4.67, with a P/E of 374.5, a -36.2% profit margin and revenue growth of 6.5%. It does not pay a dividend. Vestovix scores it 39/100 overall. Its strongest dimension is Growth (60/100) and its weakest is Value (13/100). Its volatility is roughly in line with the market.

Price

$4.67

Market cap

$511.4M

P/E ratio

374.5

Dividend yield

None

Beta

1.19

52-week range

$3.28 to $6.18